Joint Formulary & PAD

Emtricitabine and tenofovir disoproxil - Pre-exposure prophylaxis of HIV-1 infection

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Tablets
Associated Icons :
BNF SPC
NHSE
R
Restrictions / Comments :
Important
Pre-exposure prophylaxis (PrEP) is available through Sexual Health clinics for people at risk. Use as recommended by BHIVA/BASHH guidelines

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Emtricitabine and tenofovir disoproxil
Indication :
Pre-exposure prophylaxis of HIV-1 infection
Group Name :
Keywords :
PrEP, PREP, Sexual Health, GUM
Brand Names Include :
Truvada
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Emtricitabine and tenofovir disoproxil is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Pre-exposure prophylaxis of HIV-1 infection.

  • No records returned.

Committee Recommendations (1)

These drugs falls under the responsibility of NHS England Specialised Commissioning and should therefore not be prescribed in Primary Care.

Clinicians / specialists within the Acute setting should only prescribe in line with their Trust formulary / pharmacy advice.

GPs should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient’s medication.